TrialClinical and vaccine immunology : CVI2011

Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial.

Mel Krajden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.